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COMMONWEALTH OF MASSACHUSETTS 
BOARD OF REGISTRATION IN PHARMACY 
 
MINUTES OF THE REGULARLY SCHEDULED MEETING 
239 Causeway Street, Fourth Floor Room 417A 
Boston, MA 02114 
 
Tuesday, February 3, 2015 
 
 
Board Members Present     Board Member Not Present 
Patrick Gannon, RPh, Present (arrives @ 9:49AM)  Karen Conley, DNP, RN, 
Edmund Taglieri Jr., RPh, President-elect   AOCN, NEA-BC 
Richard Tinsley, MBA, MEd, Secretary 
Catherine Basile, PharmD, RPh 
Garrett Cavanaugh, RPh 
Susan Cornacchio, JD, RN (arrives @9:51AM) 
William Cox, CPht 
Timothy Fensky, RPh, FACA 
Michael Godek, RPh 
 
Board Staff Present 
David Sencabaugh, RPh, Executive Director 
David Dunn, RPh, Assistant Executive Director 
Heather Engman, Board Counsel 
Kelly Ann Barnes, Director of Pharmacy Quality Assurance 
William Frisch Jr., RPh, Director of Pharmacy Compliance 
Samuel Penta, RPh, Senior Pharmacy Investigator 
Christina Mogni, RPh, Pharmacy Investigator 
Monica Vasquez, Compliance Office 
Colleen Collins, RPh, Contract Pharmacy Investigator 
Richard Harris, Program Analyst 
 
TOPIC I. 
 
CALL TO ORDER 
 
DISCUSSION: A quorum of the Board was present. President-elect E. TAGLIERI 
chaired the meeting and asked if anyone in the audience was recording the meeting; no 
one indicated that they were recording the meeting. President elect E.TAGLIERI, also 
announced that the Board was recording the meeting. 
ACTION: At 8:50AM E.TAGLIERI, called the February 3, 2015, meeting of the Board 
of Registration in Pharmacy to order. Board member attendance was indicated by roll 
call: E. TAGLIERI; yes, R.TINSLEY; yes, C.BASILE; yes, G CAVANAUGH; yes, W 
COX; yes, T FENSKY; yes; M GODEK; yes; 
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P GANNON and S CORNACCHIO, were not present at the time of roll call 
 
 
TOPIC II. 
 
APPROVAL OF AGENDA 
 
DISCUSSION: Approval of the minutes and the file review for Park Avenue Pharmacy 
will be deferred to a future meeting. 
ACTION: Motion by R.TINSLEY, seconded by C. BASILE, and voted unanimously to 
accept the agenda with the noted change. P. GANNON and S. CORNACCHIO were not 
present for the discussion or vote of this matter. 
 
TOPIC III.        9:05AM 
REPORTS 
Applications Approved Pursuant to Licensure Policy 13-01 
DISCUSSION: R HARRIS noted that during the past month there has been twenty six 
(26) change of managers, and one (1) new community pharmacy. 
ACTION: So noted, P.GANNON and S.CORNACCHIO were not present for the 
presentation of the report. 
 
 
TOPIC IV.  
FILE REVIEW 
SA-INV-3639, Stat-Care Pharmacy,  
Presented by: Christina Mogni, RPh, Pharmacy Investigator 
DISCUSSION: The case was presented and summarized by Pharmacy Investigator 
MOGNI. The Staff Assignment was open based on information provided by the Drug 
Enforcement Agency (DEA) Boston office regarding an excessive amount of Schedule II 
narcotic emergency prescription requiring hard copy back-up self- reported by Stat Care 
Pharmacy. The Board was concerned regarding the high number of emergency schedule 
prescriptions, it was noted that emergency Schedule II prescriptions is common in the 
long term care setting for continuity of care. The Board was satisfied with efforts by Stat 
Care Pharmacy to obtain the outstanding prescriptions, Plan of Correction, and 
cooperation with the DEA. 
ACTION: Motion by FENSKY, seconded by C.BASILE, and voted unanimously to close 
the staff assignment with no discipline warranted. P.GANNON and S. CORNACCHIO 
were not present for the discussion or vote of this matter. 
 
FILE REVIEW  
2.SA-INV-3691, Pharmacy Corporation of America 
Presented by, Colleen Collins, RPh. Contract Investigator 
DISCUSSION: C. COLLINS presented and summarized the Staff Assignment. The 
investigation was initiated as the result of a complaint by Ther-Rx that the Pharmacy 
Corporation of America’s Brockton facility was compounding hydroxyprogesterone 
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caproate injection, commercially available as Makena®. Pharmacy Corporation of 
America was able to provide records indicating that it had not compounded any 
hydroxyprogesterone caproate injection. 
ACTION: Motion by R.TINSLEY, and seconded by M.GODEK, and voted unanimously, 
to close the staff assignment with no violation. P.GANNON and S. CORNACCHIO were 
not present for the discussion or vote of this matter. 
 
 
TOPIC V. 
APPLICATIONS 
Application for a New Community Pharmacy 
1. Soleo Health, 5 Shawmut Road, Canton 
DISCUSSION: MOR Bridget Smith presented this application. Soleo Health will be a 
Home Infusion Pharmacy. MOR Smith indicated that there would be no USP <795> 
compounding and that Soleo is seeking waivers for compounding. It was noted that 
Schedule VI medications was not checked off on the application. MOR Smith indicated 
that she would amend the application. 
ACTION: Motion by M.GODEK , seconded by T.FENSKY, and voted unanimously to 
approve Soleo Health Application and waivers pending a (1) successful inspection, (2) 
receipt of <795> and <797> Attestations (3) amended application. P.GANNON and S. 
CORNACCHIO were not present for the discussion or vote of this matter. 
 
TOPIC V. 
APPLICATIONS        9:36AM 
Application for Renovation / Expansion Request for Board Approval 
2. Integriscript,  95B Ashley Ave, west Springfield,  DS89726 
DISCUSSION: MOR Roman Szarek and Larry Kioski Operations Manager presented the 
application for expansion of Integriscripts facility. The proposed expansion indicates an 
increase of 3650 sq ft. Operations Manager Kioski noted that the increase space was need 
in order service the approximately 2000 long-term care beds. Board Counsel 
H.ENGMAN advised the Board that there are currently open complaints against 
Integriscript that are pending board counsel.  The Board authorized resolution of those 
matters with a consent agreement for probation.  Board counsel indicated that pending 
complaints do not necessarily impact Board’s decision on pending application.   W. 
FRISCH was concerned regarding the impact of the construction on the compounding 
facility. W. FRISCH inquired regarding a containment plan for construction particulate 
matter, environmental monitoring of the classified space. W.FRISCH displayed concerns 
regarding the following items of the renovation request: policy and procedures for the 
night drop off box, Supervision of the new narcotic room, and supervision of the clean 
room. The representatives from Integriscript were able satisfactorily address each 
concern. 
ACTION: Motion by C.BASILE, seconded by G. CAVANAUGH, and voted 
unanimously to approve the renovation pending successful inspection 
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TOPIC: VI. 
REGULATIONS      Time: 9:17 – 9:47AM 
1. Proposed amendments to 247 CMR 9.00 Code of Professional Conduct; Professional 
Standards for Registered Pharmacists, Pharmacies, and Pharmacy Departments. 
DISCUSSION: The draft proposed regulation was displayed on screen for Board 
members and the audience to view. Board Counsel H. ENGMAN captured Board 
members concerns and changes to the Draft document via track changes on screen for 
Board members and the audience to view.  
 
 
    Break 9:47AM- 9:55AM 
 
 
TOPIC VII. 
APPLICATIONS 
Application a Renovation / Expansion for Board Approval 
Critical Care Systems  a Walgreens Company, 191 Bay State Drive, Braintree DS 3327 
RECUSAL: M. GODEK recused himself and was not present for the discussion or vote 
on this matter.   
DISCUSSION: MOR Kelvin Ma, presented this application. W. FRISCH and K. 
BARNES indicated that they have been involved in multiple discussions with MOR MA 
and Walgreens representatives. W. FRISCH noted that due to inspectional deficiencies 
Critical Care System of Braintree has been closed down since June of 2014. K. BARNES 
informed that Board that as a result of on-going collaboration Critical Care System was 
seeking the approval to remake its cleanroom. 
ACTION: Motion by C.BASILE, seconded by R. TINSLEY, and voted unanimously to 
approve the Critical Care System’s application for Renovation / Expansion pending a 
successful inspection. 
 
TOPIC VIII. 
FLEX SESSION 
DISCUSSION:  
D. SENCABAUGH introduced Pharmacy Intern Emily Walker from Northeastern 
University. 
D. SENCABAUGH introduced new Board Member Susan Cornacchio, Public Member 
with expertise in Patient Safety and Quality Assurance. 
D. SENCABAUGH made members aware of the need for additional meeting dates for 
possible day and evening meetings to keep Regulations and monthly Board activity on 
track. 
D. SENCABAUGH addressed the audience to keep apprised of the website for future 
meeting dates. 
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LUNCH BREAK   TIME 12:36PM- 1:30PM 
 
TOPIC IX. 
Executive Session (M.G.L. c. 30A§ 21 (a) (1) 
DISCUSSION: P GANNON, noted that the Board would not return to open session 
following closed session. 
ACTION: At 1:49 PM Motion by E.TAGLIERI, seconded by M. GODEK, and voted 
unanimously by roll call to enter into Executive Session, P.GANNON; yes, 
E.TAGLIERI; yes, R.TINSLEY; yes, C.BASILE; yes, G.CAVANAUGH; yes, W. COX; 
yes, S. CORNACCHIO; yes, T. FENSKY; yes, M.GODEK; yes. 
 
TOPIC X. 
 
M.G.L. c 112, 65C SESSION 
DISCUSSION: NONE 
ACTION: At 2:46PM Motion by E. TAGLIERI, seconded by C.BASILE, and voted 
unanimously to enter into M.G.L. c 112, 65C. Session. 
 
TOPIC XII. 
AJOURNMENT of the Meeting 
DISCUSSION: P.GANNON, extended his appreciation to fellow members and staff for 
their patience and understanding as many battled commuting issue. P.GANNON wanted 
recognize Board Staff for its dedication and hard work in support of the Board. 
ACTION: At 4:51PM Motion by M.GODEK, seconded by G.CAVANAUGH, voted 
unanimously to adjourn the meeting. 
 
 
 
Respectfully Submitted, 
 
 
 
Richard J. Tinsley, M.B.A, M.Ed. 
Secretary 
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  List of Exhibits Referenced During the Meeting 
 
1. Preliminary Agenda for the February 3, 2015 meeting. 
2. Critical Care Systems Application for Renovation / Expansion Request for Board 
Approval 
3. Soleo Health, Inc. Application to Operate and Manage a New Community Pharmacy 
4. Integriscript, Application for Renovation / Expansion Request for Board for Board 
Approval 
5. Report of Applications approved pursuant to Licensure Policy 13-01 
6. List of proposed additional meeting dates 
7. Board Policy 13-02 Plan of Correction  
8. Investigative report SA-INV-3639 regarding the matter of Stat-Care Pharmacy 
9. Investigative report SA-INV-3691 regarding the matter of Pharmacy Corporation of 
America 
10. Draft Proposed Regulation: 247 CMR 9:00, Code of Professional Conduct; 
Professional Standards for Registered Pharmacist, Pharmacies, and Pharmacy 
Departments 
11. Draft Proposed Regulation: 247 CMR9:00, Code of Professional Conduct; 
Professional Standards for Registered Pharmacists, Pharmacies, and Pharmacy 
Departments –with track changes. 
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